Antimicrobials and Resistance: Opportunities and Challenges (T4)
OVERVIEW
Antimicrobials and Resistance: Opportunities and Challenges (T4) is organized by Keystone Symposia on Molecular and Cellular Biology and would be held during Oct 29 - Nov 01, 2017 at Eldorado Hotel & Spa Santa Fe, Santa Fe, New Mexico, United States of America.
Antimicrobial-resistant (AMR) infections claim hundreds of thousands of lives around the globe annually. This problem is exacerbated by a steady increase in global antimicrobial use and abuse in the clinic and agriculture, and a dearth of novel antimicrobials making it to market. If these scenarios continue unchecked, AMR will cumulatively cost the global economy at least 100 trillion dollars by 2050. This conference focuses on the latest work understanding and combatting AMR, including clinical perspectives on AMR diagnostics and management, translational academic perspectives on design of drug regimens and combinations that suppress AMR, pharma perspectives on recent successes and failures in novel antimicrobial development and clinical trials, and basic science perspectives on the ecology and transmission of evolving AMR determinants. While these stakeholders are similarly motivated to identify and develop therapies to treat the exceptional, unmet medical need of worsening AMR, their spheres rarely overlap at scientific conferences, leading to communication barriers between subject matter experts. This conference attempts to address this challenge by engaging diverse global perspectives on these topics, including speakers and attendees from academic research, industrial drug development, and healthcare practice and policy.
Session Topics :
• Surveillance and Treatment of Resistant Bacterial Infections in Clinical Practice
• Workshop 1: Novel Therapeutic Strategies
• Fate and Lessons Learned from Recent Drug Development Programs Focused on Resistant Pathogens or Narrow-Spectrum Agents
• Alternative Approaches to Tackling Resistant Infections
• Multidrug Evolutionary Strategies to Invert Resistance Selection
• Ecology and Evolution of AMR Transmission Dynamics Across Habitats
• Workshop 2: Novel Strategies for AMR Discovery, Diagnostics and Modeling
• Tackling AMR – Challenges in Drug Development
Antimicrobial-resistant (AMR) infections claim hundreds of thousands of lives around the globe annually. This problem is exacerbated by a steady increase in global antimicrobial use and abuse in the clinic and agriculture, and a dearth of novel antimicrobials making it to market. If these scenarios continue unchecked, AMR will cumulatively cost the global economy at least 100 trillion dollars by 2050. This conference focuses on the latest work understanding and combatting AMR, including clinical perspectives on AMR diagnostics and management, translational academic perspectives on design of drug regimens and combinations that suppress AMR, pharma perspectives on recent successes and failures in novel antimicrobial development and clinical trials, and basic science perspectives on the ecology and transmission of evolving AMR determinants. While these stakeholders are similarly motivated to identify and develop therapies to treat the exceptional, unmet medical need of worsening AMR, their spheres rarely overlap at scientific conferences, leading to communication barriers between subject matter experts. This conference attempts to address this challenge by engaging diverse global perspectives on these topics, including speakers and attendees from academic research, industrial drug development, and healthcare practice and policy.
Session Topics :
• Surveillance and Treatment of Resistant Bacterial Infections in Clinical Practice
• Workshop 1: Novel Therapeutic Strategies
• Fate and Lessons Learned from Recent Drug Development Programs Focused on Resistant Pathogens or Narrow-Spectrum Agents
• Alternative Approaches to Tackling Resistant Infections
• Multidrug Evolutionary Strategies to Invert Resistance Selection
• Ecology and Evolution of AMR Transmission Dynamics Across Habitats
• Workshop 2: Novel Strategies for AMR Discovery, Diagnostics and Modeling
• Tackling AMR – Challenges in Drug Development
KEY DATES
29 Oct, 2017
Event Start Date
01 Nov, 2017
Event End Date
SPECIALITIES
Immunology and MicrobiologySUGGESTED HOTELS
CONFERENCE VENUE
Eldorado Hotel & Spa Santa FeRELATED CONFERENCES & LIVE WEBINARS
Quick Links